Literature DB >> 6382822

Mycoplasma pneumoniae respiratory disease symposium: summation and significance.

W A Clyde.   

Abstract

The symposium on M. pneumoniae respiratory disease has examined the clinical expression of infection in adults and children, the pathophysiologic disturbances which occur, and the laboratory diagnosis by isolation and serology. That these infections are very common has been well documented; however, a variable incidence over periods of several years tends to minimize importance of the disease for many clinicians. While good laboratory diagnostic methods exist, they provide retrospective insight predominantly and are not useful for early diagnosis or therapeutic decision making. Development of rapid diagnostic methods which are sensitive and specific is an important goal for future research. Success would facilitate our understanding and control of M. pneumoniae disease.

Entities:  

Mesh:

Year:  1983        PMID: 6382822      PMCID: PMC2590548     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  9 in total

1.  A rapid test for the presence of increased cold agglutinins.

Authors:  D H GARROW
Journal:  Br Med J       Date:  1958-07-26

2.  Mycoplasma and adenovirus pneumonias. Comparison with other atypical pneumonias in a military population.

Authors:  R B George; M M Ziskind; J R Rasch; W J Mogabgab
Journal:  Ann Intern Med       Date:  1966-11       Impact factor: 25.391

3.  The unusual severity of Mycoplasmal pneumonia in children with sickle-cell disease.

Authors:  S T Shulman; J Bartlett; W A Clyde; E M Ayoub
Journal:  N Engl J Med       Date:  1972-07-27       Impact factor: 91.245

Review 4.  Mycoplasma pneumoniae disease: clinical spectrum, pathophysiology, epidemiology, and control.

Authors:  F W Denny; W A Clyde; W P Glezen
Journal:  J Infect Dis       Date:  1971-01       Impact factor: 5.226

5.  Rapid screening for cold agglutinins in pneumonia.

Authors:  J P Griffin
Journal:  Ann Intern Med       Date:  1969-04       Impact factor: 25.391

6.  Frequency of Mycoplasma pneumoniae pneumonia.

Authors:  H M Foy; I D Allan
Journal:  Lancet       Date:  1982-02-13       Impact factor: 79.321

7.  Pathogenic mycoplasmas: cultivation and vertebrate pathogenicity of a new spiroplasma.

Authors:  J G Tully; R F Whitcomb; H F Clark; D L Williamson
Journal:  Science       Date:  1977-03-04       Impact factor: 47.728

8.  Pneumonia due to Mycoplasma pneumoniae. Its incidence in the membership of a co-operative medical group.

Authors:  E R Alexander; H M Foy; G E Kenny; R A Kronmal; R McMahan; E R Clarke; W A MacColl; J T Grayston
Journal:  N Engl J Med       Date:  1966-07-21       Impact factor: 91.245

9.  The epidemiology of tracheobronchitis in pediatric practice.

Authors:  R S Chapman; F W Henderson; W A Clyde; A M Collier; F W Denny
Journal:  Am J Epidemiol       Date:  1981-12       Impact factor: 4.897

  9 in total
  17 in total

1.  Rapid, sensitive detection of Mycoplasma pneumoniae in simulated clinical specimens by DNA amplification.

Authors:  G E Buck; L C O'Hara; J T Summersgill
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

Review 2.  Bacterial challenges and evolving antibacterial drug strategy.

Authors:  B Watt; J G Collee
Journal:  Postgrad Med J       Date:  1992-01       Impact factor: 2.401

3.  Isolation of Mycoplasma pneumoniae from respiratory tract specimens in Ontario.

Authors:  C Fleming; D Hodge; S Toma; R Dular; S Kasatiya
Journal:  CMAJ       Date:  1987-07-01       Impact factor: 8.262

4.  Evaluation of LBM415 (NVP PDF-713), a novel peptide deformylase inhibitor, for treatment of experimental Mycoplasma pneumoniae pneumonia.

Authors:  Monica Fonseca-Aten; Christine M Salvatore; Asunción Mejías; Ana M Ríos; Susana Chávez-Bueno; Kathy Katz; Ana M Gómez; George H McCracken; R Doug Hardy
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

5.  Mycoplasma pneumoniae pneumonia: CT features in 16 patients.

Authors:  Inho Lee; Tae Sung Kim; Hye-Kyung Yoon
Journal:  Eur Radiol       Date:  2005-10-08       Impact factor: 5.315

6.  16S rRNA based polymerase chain reaction compared with culture and serological methods for diagnosis of Mycoplasma pneumoniae infection.

Authors:  F J van Kuppeveld; K E Johansson; J M Galama; J Kissing; G Bölske; E Hjelm; J T van der Logt; W J Melchers
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-05       Impact factor: 3.267

7.  The principal protein antigens of isolates of Mycoplasma pneumoniae as measured by levels of immunoglobulin G in human serum are stable in strains collected over a 10-year period.

Authors:  A C Vu; H M Foy; F D Cartwright; G E Kenny
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

8.  Depletion of alveolar macrophages exacerbates respiratory mycoplasmosis in mycoplasma-resistant C57BL mice but not mycoplasma-susceptible C3H mice.

Authors:  J M Hickman-Davis; S M Michalek; J Gibbs-Erwin; J R Lindsey
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

9.  Parameters of Mycoplasma pneumoniae infection in Syrian hamsters.

Authors:  M F Barile; D K Chandler; H Yoshida; M W Grabowski; R Harasawa; S Razin
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

Review 10.  The infectious march: the complex interaction between microbes and the immune system in asthma.

Authors:  Terianne Wong; Gary Hellermann; Shyam Mohapatra
Journal:  Immunol Allergy Clin North Am       Date:  2010-11       Impact factor: 3.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.